Mayne Pharma Group Limited

OTCPK:MAYN.F Stock Report

Market Cap: US$367.5m

Mayne Pharma Group Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

OTCPK:MAYN.F Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
14 Mar 24BuyUS$995,456UBS Asset Management AGCompany217,138US$4.58
14 Mar 24SellUS$1,425,107UBS Asset Management AGCompany311,656US$4.57
08 Mar 24BuyUS$126,827UBS Asset Management AGCompany27,522US$4.64
08 Mar 24SellUS$213,676UBS Asset Management AGCompany46,490US$4.62
07 Mar 24BuyUS$1,841,699UBS Asset Management AGCompany399,486US$4.61
07 Mar 24BuyUS$205,970Credit Suisse Asset Management (Switzerland) Ltd.Company44,430US$4.64
07 Mar 24SellUS$2,605,673UBS Asset Management AGCompany567,908US$4.59
01 Mar 24BuyUS$3,415,118UBS Asset Management AGCompany797,712US$4.28
01 Mar 24SellUS$2,889,953UBS Asset Management AGCompany673,765US$4.29
26 Feb 24BuyUS$1,809,136UBS Asset Management AGCompany459,566US$3.94
26 Feb 24SellUS$889,391UBS Asset Management AGCompany227,471US$3.91
23 Feb 24BuyUS$23,947,310UBS Asset Management AGCompany6,915,901US$3.46
23 Feb 24SellUS$21,447,514UBS Asset Management AGCompany6,192,570US$3.46
12 Dec 23BuyUS$17,600,992Goldman Sachs Group, Investment Banking and Securities InvestmentsCompany4,682,116US$3.76
01 Dec 23BuyUS$25,843Frank CondellaIndividual7,154US$3.61
31 Oct 23BuyUS$12,571,016Goldman Sachs Group, Investment Banking and Securities InvestmentsCompany5,250,334US$2.39
31 Oct 23SellUS$22,833,499Goldman Sachs Group, Investment Banking and Securities InvestmentsCompany9,620,038US$2.37
25 Oct 23BuyUS$43,783Kathryn MacFarlaneIndividual18,000US$2.43
24 Oct 23BuyUS$89,448Shawn O’BrienIndividual37,041US$2.41
23 Oct 23BuyUS$26,019Ann CustinIndividual12,287US$2.12
02 Aug 23SellUS$8,007Goldman Sachs Asset Management, L.P.Company2,658US$3.01
24 Jul 23BuyUS$3,304,049Viburnum Funds Pty Ltd.Company1,123,793US$2.94
23 Jun 23BuyUS$425,501Goldman Sachs Group, Investment Banking and Securities InvestmentsCompany162,392US$2.62
23 Jun 23SellUS$317,492Goldman Sachs Group, Investment Banking and Securities InvestmentsCompany120,527US$2.67
21 Jun 23SellUS$11,040,042Mithra Pharmaceuticals SACompany4,221,815US$2.61
19 Jun 23BuyUS$17,445,885Goldman Sachs Group, Investment Banking and Securities InvestmentsCompany7,470,185US$2.34
16 Jun 23BuyUS$887,644Blackstone Inc.Company341,518US$2.60
16 Jun 23BuyUS$887,644Blackstone Alternative Asset Management L.P.Company341,518US$2.60
13 Jun 23SellUS$73,957Lazard Asset Management LLCCompany27,714US$2.67
30 May 23BuyUS$2,028,200Viburnum Funds Pty Ltd.Company874,278US$2.32
29 May 23BuyUS$7,112Lazard Asset Management LLCCompany2,891US$2.46
23 May 23BuyUS$79,971Lazard Asset Management LLCCompany32,937US$2.43
19 May 23SellUS$3,110,607Lazard Asset Management LLCCompany1,247,552US$2.49
11 May 23BuyUS$158,860Lazard Asset Management LLCCompany60,769US$2.61
08 May 23BuyUS$1,410,603Viburnum Funds Pty Ltd.Company511,541US$2.76

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of MAYN.F?
Owner TypeNumber of SharesOwnership Percentage
Public Companies4,221,8155.2%
Private Companies4,760,3195.87%
VC/PE Firms6,428,2687.92%
Individual Insiders8,409,40410.4%
Institutions26,781,67933%
General Public30,546,47437.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 60.43% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
7.92%
Viburnum Funds Pty Ltd.
6,428,268US$29.1m0%8.64%
6.52%
Bruce Mathieson
5,292,066US$24.0m0%no data
6.43%
Goldman Sachs Group, Investment Banking and Securities Investments
5,218,110US$23.6m-6.84%0.01%
5.23%
Lazard Asset Management LLC
4,240,774US$19.2m0%0.02%
5.2%
Mithra Pharmaceuticals SA
4,221,815US$19.1m0%no data
4.56%
Rubric Capital Management LP
3,700,223US$16.8m0%0.55%
4.18%
Investors Mutual Limited
3,389,914US$15.4m0%4.26%
4.13%
The Vanguard Group, Inc.
3,354,047US$15.2m0.28%no data
2.33%
UBS Asset Management AG
1,889,905US$8.6m36.6%no data
2.1%
Credit Suisse Asset Management (Switzerland) Ltd.
1,701,480US$7.7m0%0.01%
1.6%
Gft 2 Co Pty Limited
1,295,569US$5.9m0%no data
1.58%
Dimensional Fund Advisors LP
1,283,206US$5.8m2.7%no data
1.58%
Scott Richards
1,280,210US$5.8m0%no data
0.99%
IVL Group Pty Ltd
800,000US$3.6m0%no data
0.92%
Vivnat (Curtin) Pty Ltd
750,000US$3.4m0%no data
0.69%
Norges Bank Investment Management
556,697US$2.5m-33%no data
0.64%
Roger Corbett
522,028US$2.4m0%no data
0.62%
Y S Chains Pty Ltd
500,000US$2.3m0%no data
0.57%
Retzos Executive Pty Ltd
465,000US$2.1m0%no data
0.49%
Kon Tzimokas
400,000US$1.8m0%no data
0.46%
Australian Super Pty Ltd
374,563US$1.7m0%no data
0.45%
Peter Paltoglou
365,626US$1.7m0%no data
0.44%
Wal Assets Pty Ltd
354,500US$1.6m0%no data
0.42%
Blackstone Inc.
341,518US$1.5m0%0.01%
0.39%
Blackstone Alternative Asset Management L.P.
314,685US$1.4m0%0.96%
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.